Electroceuticals, hailed as the next frontier in medicine, is garnering considerable interest from medical researchers and entrepreneurs on the lookout for the next class of therapies.
Since time immemorial, the idea of a miracle cure to rid all the ailments afflicting the human body have held tremendous fascination for scientists, medical researchers, alternative medicine practitioners and even faith healers. Could it be that the panacea the world’s looking for is nothing but electricity? The concept might not have had too many takers a few decades earlier, but today ‘electroceuticals’ a term used to describe miniature devices which can alter electrical signals diffused by nerves throughout the body to treat a wide range of illnesses, is being touted as the next great frontier in medicine.
Gaining ground
Also known as bioelectric medicine, it is has generated considerable interest globally among medical researchers and entrepreneurs. Leading medical device manufacturers like Medtronics, Boston Scientific Corporation, Cochlear and even pharma majors like GlaxoSmithKline (GSK) are making significant investments for research in this arena. Even organisations like the Defense Advanced Research Projects Agency (DARPA) and National Institutes of Health (NIH) in the US have shown immense interest in the field of electroceuticals.
DARPA, an agency of the US Department of Defense in charge of the development of emerging technologies for military use, has initiated a $79 million project called Electrical Prescriptions (ElectRx), in this field. NIH's Stimulating Peripheral Activity to Relieve Conditions (SPARC) programme is another initiative that seeks to expand our current knowledge of nerve-organ interactions and propel progress in the field of neuromodulation. In October 2016, NIH also announced $20 million in funding for the field. The endeavour’s goal is to understand more about the body’s electrical circuit – the peripheral nervous system.
Catalysts of change
Denne historien er fra March 1, 2017-utgaven av Express Pharma.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra March 1, 2017-utgaven av Express Pharma.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
UNLOCKING GROWTH FRONTIERS
Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik
Accelerating pharma's sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core pharma business strategy is essential for long-term success, analyses key focus areas and policy pushes which can incentivise companies to further evolve on the sustainability path
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases
Optimising spend, maximising growth
Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation